| 发明名称 |
USE OF GDNF FOR TREATING CORNEAL DEFECTS |
| 摘要 |
The present invention relates to the use of a glial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/or a nucleic acid containing at least a nucleotide sequence encoding the primary amino ac id sequence of GDNF or the functionally active derivative or part thereof and/o r of the agonist for the manufacture of a pharmaceutical composition for epidermal and stromal wound healing.
|
| 申请公布号 |
CA2385929(A1) |
申请公布日期 |
2001.05.03 |
| 申请号 |
CA20002385929 |
申请日期 |
2000.10.30 |
| 申请人 |
BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA MB H</ |
发明人 |
KRUSE, FRIEDRICH;HANKE, MICHAEL;POHL, JENS;PAULISTA, MICHAEL |
| 分类号 |
A61K9/06;A61F9/007;A61K9/08;A61K31/573;A61K35/12;A61K38/18;A61K38/22;A61K39/395;A61K45/00;A61K45/06;A61K47/36;A61K48/00;A61P1/02;A61P3/10;A61P17/00;A61P17/02;A61P19/02;A61P25/00;A61P27/02;A61P29/00;A61P31/00;A61P31/10;A61P31/12;A61P35/04;A61P37/00;A61P37/06;A61P43/00;(IPC1-7):A61K38/18;A61K38/48 |
主分类号 |
A61K9/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
